These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2534879)

  • 21. [Drugs in Poland: a review of literature on the symptoms of side effects].
    Rudzki E
    Derm Beruf Umwelt; 1985; 33(4):136-9. PubMed ID: 2931265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management of clinical or biological abnormalities during therapeutic trials].
    Benichou C; Danan G; Vigeral P
    Therapie; 1988; 43(6):465-8. PubMed ID: 2976214
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug hypersensitivity in the age of electronic medical records.
    Young AL; Marji J; Grossman ME
    J Drugs Dermatol; 2011 Dec; 10(12):1430-1. PubMed ID: 22134567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Friction skin test in fixed erythema].
    GONCALVES AP
    An Bras Derm Sifilogr; 1956 Sep; 31(3):115-24. PubMed ID: 13403197
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies of leukocyte adherence inhibition (LAI) tests in patients with drug eruptions].
    Matsumoto Y; Ogawa K
    Arerugi; 1983 Jan; 32(1):8-13. PubMed ID: 6222722
    [No Abstract]   [Full Text] [Related]  

  • 26. Skin: major target organ of allergic reactions to small molecular weight compounds.
    Merk HF; Baron JM; Neis MM; Obrigkeit DH; Karlberg AT
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):313-7. PubMed ID: 17462686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug allergy].
    Pichler WJ
    Ther Umsch; 1994 Jan; 51(1):55-60. PubMed ID: 8146813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical analysis of 410 cases of drug eruption].
    Mo BH
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):183, 186. PubMed ID: 12581979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral provocation: limitations.
    Girard M
    Semin Dermatol; 1989 Sep; 8(3):192-5. PubMed ID: 2534883
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral provocation: uses.
    Kauppinen K; Alanko K
    Semin Dermatol; 1989 Sep; 8(3):187-91. PubMed ID: 2534882
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug eruptions: the value of oral rechallenge test and patch test.
    Puavilai S; Chunharas A; Kamtavee S; Pongwiriyapanich S
    J Med Assoc Thai; 2002 Feb; 85(2):263-9. PubMed ID: 12081129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The downside of a drug-crazed world.
    Neilson EG
    J Am Soc Nephrol; 2006 Oct; 17(10):2650-1. PubMed ID: 16959823
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pathogenetic significance of a decrease in the alpha-tocopherol level in drug-induced disease].
    Soloshenko EN; Paranich AV
    Vestn Dermatol Venerol; 1987; (9):14-6. PubMed ID: 2962393
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug hypersensitivity reactions: from clinical manifestations to an allergologic diagnosis.
    Bach S; Bircher AJ
    Eur Ann Allergy Clin Immunol; 2005 Jun; 37(6):213-8. PubMed ID: 16156399
    [No Abstract]   [Full Text] [Related]  

  • 35. Three cases of toxic skin eruptions associated with methotrexate and a compilation of methotrexate-induced skin eruptions.
    Scheinfeld N
    Dermatol Online J; 2006 Dec; 12(7):15. PubMed ID: 17459301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced cutaneous pathology.
    Ramdial PK; Naidoo DK
    J Clin Pathol; 2009 Jun; 62(6):493-504. PubMed ID: 19155238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fixed drug eruption in Nigeria.
    Nnoruka EN; Ikeh VO; Mbah AU
    Int J Dermatol; 2006 Sep; 45(9):1062-5. PubMed ID: 16961509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Skin side effects of preparations with cardiovascular action].
    Romanenko GF; Mozherenkov VP
    Vestn Dermatol Venerol; 1984 Feb; (2):25-8. PubMed ID: 6232772
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug allergies and drug hypersensitivities].
    Demoly P
    Rev Prat; 2007 Jun; 57(12):1326-30. PubMed ID: 17717945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. THE ECONOMICS OF ADVERSE DRUG REACTIONS--case studies.
    Visconti JA; Smith MC
    Ann Pharmacother; 2006 Mar; 40(3):529-36. PubMed ID: 16507611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.